Invention Grant
US09248148B2 Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections 有权
单羟基(羟基吡喃酮铁)和组合(铁羟基吡喃酮和GI炎症抑制剂)用于贫血或幽门螺杆菌感染的组合物

  • Patent Title: Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections
  • Patent Title (中): 单羟基(羟基吡喃酮铁)和组合(铁羟基吡喃酮和GI炎症抑制剂)用于贫血或幽门螺杆菌感染的组合物
  • Application No.: US12992528
    Application Date: 2009-05-14
  • Publication No.: US09248148B2
    Publication Date: 2016-02-02
  • Inventor: Michael Arthur Stockham
  • Applicant: Michael Arthur Stockham
  • Applicant Address: CH Wollerau
  • Assignee: Iron Therapeutics Holdings AG
  • Current Assignee: Iron Therapeutics Holdings AG
  • Current Assignee Address: CH Wollerau
  • Agency: K&L Gates LLP
  • Priority: GB0808835.3 20080515
  • International Application: PCT/GB2009/001231 WO 20090514
  • International Announcement: WO2009/138761 WO 20091119
  • Main IPC: A01N59/16
  • IPC: A01N59/16 A61K33/00 A61K31/4439 A61K33/26
Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections
Abstract:
There is provided a composition or kit of parts comprising: one or more compounds capable of treating and/or preventing an inflammatory disease of the gastrointestinal tract: and an iron hydroxypyrone, for increasing the level of iron in a patient's bloodstream and/or treating and/or preventing anaemia such as iron deficiency anaemia. A composition comprising iron hydroxypyrone is also provided for administration to a subject: having or at risk of having achlorhydria; wherein the gastric pH of the subject is equal to or greater than about 4; or wherein the subject has an inflammatory disease of the gastrointestinal tract.
Information query
Patent Agency Ranking
0/0